Effective Tetradentate Compound Complexes against Leishmania spp. that Act on Critical Enzymatic Pathways of These Parasites
MetadataShow full item record
AuthorUrbanová, Kristína; Ramírez Macías, Inmaculada; Martín-Escolano, Rubén; Rosales Lombardo, María José; Cussó, Olaf; Serrano, Joan; Company, Anna; Sánchez-Moreno, Manuel; Costas, Miquel; Ribas, Xavi; Marín Sánchez, Clotilde
AmastigoteAntileishmaniaAntiproliferativeLeishmania spp.PromastigoteSODTetradentate polyaminic compoundsUltrastructure
Urbanová, K. [et al.]. Effective Tetradentate Compound Complexes against Leishmania spp. that Act on Critical Enzymatic Pathways of These Parasites. Molecules 2019, 24, 134; doi:10.3390/molecules24010134.
SponsorshipThis research was funded by THE SPANISH MINISTRY OF ECONOMY AND COMPETITIVENESS (MINECO), CONSOLIDER-INGENIO 2010, grant number CDS2010-00065; THE EUROPEAN RESEARCH FOUNDATION, grant number ERC-2009-StG-239910; THE MICINN, grant number CTQ2009-08464; and INNPLANTA, grant number INP-2011-0059-PCT-420000-ACT1.
The spectrum and efficacy of available antileishmanial drugs is limited. In the present work we evaluated in vitro the antiproliferative activity of 11 compounds based on tetradentate polyamines compounds against three Leishmania species (L. braziliensis, L. donovani and L. infantum) and the possible mechanism of action. We identified six compounds (3, 5, 6, 7, 8 and 10) effective against all three Leishmania spp both on extracellular and intracellular forms. These six most active leishmanicidal compounds also prevent the infection of host cells. Nevertheless, only compound 7 is targeted against the Leishmania SOD. Meanwhile, on the glucose metabolism the tested compounds have a species-specific effect on Leishmania spp.: L. braziliensis was affected mainly by 10 and 8, L. donovani by 7, and L. infantum by 5 and 3. Finally, the cellular ultrastructure was mainly damaged by 11 in the three Leishmania spp. studied. These identified antileishmania candidates constitute a good alternative treatment and will be further studied.